Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administration
- 1 September 1983
- journal article
- other
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 58 (3-4) , 299-304
- https://doi.org/10.1007/bf01252815
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Central and peripheral dopamine beta hydroxylase: Responses to long term treatment with monoamine oxidase inhibitorsNeuropharmacology, 1980
- Biochemical alterations of dopamine receptor responses following chronic l-dopa therapyBiochemical Pharmacology, 1980
- Dopamine Conjugate in Cerebrospinal FluidJournal of Neurochemistry, 1980
- A biochemical measure of monoamine oxidase type A and B inhibitor effects in manJournal of Psychiatric Research, 1979
- Simultaneous radioenzymatic assay of catecholamines and dihydroxy-phenylacetic acid /DOPAC/; comparison of the effects of drugs on the tuberoinfundibular and striatal dopamine metabolism and on plasma prolactin levelLife Sciences, 1978
- Experiences with L-deprenyl in ParkinsonismJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole rangeLife Sciences, 1976
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975